Silicon Valley has seen an influx of world-renowned cardiologists lately—a phenomenon that’s likely the result of increased attention to healthcare in the tech industry—CNBC reported.

Minnesota’s attorney general filed a lawsuit on Tuesday, Oct. 16, accusing drug manufacturers Sanofi, Novo Nordisk and Eli Lilly of deceptive price increases for insulin.

The proportion of part-time cardiologists is declining at a time when one would expect health systems to be doing everything they can to keep competent physicians on board, according to MedAxiom’s 2018 Cardiovascular Provider Compensation & Production Survey.

Cardiovascular disease remains the world’s No. 1 killer, responsible for a third of global deaths every year. But, though the overall burden of CVD in developed countries is on a downward trajectory, cases of heart disease are actually increasing in some corners of the world.

Robert B. Ford has been named president and chief operating officer of Abbott, the company announced Oct. 15.

Indian-American cardiologist and serial entrepreneur Kiran Patel announced he’s investing $60 million in Concept Medical Inc., a company looking to test its novel sirolimus-coated balloon.

Heart patients across the U.K. have been cut from an international clinical trial to test a novel heart attack drug after the medicine’s manufacturers expressed concern about registering new medications in Europe post-Brexit.

In light of Hurricane Michael’s destructive landfall Wednesday in the Florida panhandle, the American Heart Association is warning cardiovascular patients to plan ahead for unexpected emergencies, as they could be at an increased risk for CVD events during the storm.